CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Oat +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02731755
NCT02731755N/ACompleted

Acute Cardiovascular Effects of Phenolic Rich Oats in Men With Above Average Blood Pressure

University of Reading·interventional·Posted Apr 8, 2016·Updated Nov 1, 2019

In Brief

A clinical study evaluating Oat and Control for Healthy. Completed, enrolled 18 participants across 2 sites.

Detailed Summary

In this proposed human trial, the investigators aim to establish whether consumption of one portion of phenolic acid-rich oats leads to acute improvements (i.e. 1-24h post-intake) in markers of cardiovascular disease risk relative to an energy matched control intervention in healthy men with high-normal to mildly elevated blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 8, 2016
Enrollment StartJan 1, 2016
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.2 years ago

Interventions

Oatother

The study oat intervention products will consist of 67.7g oatflake and 22.5g oatbran concentrate.

Controlother

60g cream of rice